ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 950,17
0,11%
Dow Jones
44 544,66
-0,75%
DAX
21 732,05
0,01%
Brent Oil
76,385
0,00%
Bitcoin
101 920,89
-0,48%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Regulus Therapeutics Inc (RGLS) Cours

Regulus Therapeutics Inc

Regulus Therapeutics Inc (RGLS)

NASDAQ
1,00
0,00
(0,00%)
Fermé 01 Février 10:00PM
Retardé de 15 minutes
1,05
0,05
(5,00%)
Après les heures de négociation: 1:33AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
1,05
Prix Achat
1,05
Prix Vente
1,06
Volume échangé
552 951
0,9595 Fourchette du Jour 1,14
0,8301 Plage de 52 semaines 3,78
Cap du marché
68,775M
Clôture Veille
1,00
Ouverture
0,9595
Dernière Transaction
100
@
1.05
(formt)
Dernière heure de transaction
Volume financier
US$ 586 651
VWAP
1,0609
Volume moyen (3 m)
390 176
Actions en circulation
65 500 134
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,18
Bénéfice par action (BPA)
-0,46
Chiffre d'affairess
-
Bénéfice net
-30,04M

À propos de Regulus Therapeutics Inc

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The comp... Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.regulusrx.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Regulus Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker RGLS. Le dernier cours de clôture d'Regulus Therapeutics était de US$1,00. Au cours de la dernière année, les actions de Regulus Therapeutics ont été négociées dans une fourchette de prix de US$ 0,8301 à US$ 3,78.

Regulus Therapeutics compte actuellement 65 500 134 actions en circulation. La capitalisation boursière d'Regulus Therapeutics est de US$65,50 million. Regulus Therapeutics a un ratio cours/bénéfice (ratio PE) de -2.18.

RGLS Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

il y a 13 heures
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

il y a 13 heures
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

30 Janvier 2025
Edgar (US Regulatory)

Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)

Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429) PR Newswire SAN DIEGO, Jan...

29 Janvier 2025
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

15 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

15 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Janvier 2025
Edgar (US Regulatory)

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences PR Newswire SAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Regulus Therapeutics Inc...

26 Novembre 2024
PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

08 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.16-13.22314049591.211.290.830112980891.00584393CS
4-0.53-33.54430379751.581.630.83016329491.13915594CS
12-0.43-29.05405405411.481.770.83013901761.33866836CS
26-0.79-42.93478260871.841.880.83013673131.48100267CS
52-0.17-13.93442622951.223.780.830111791962.17849546CS
1560.844000.213.780.15767251701.49844772CS
260-0.03-2.777777777781.083.780.157611795601.17806295CS

RGLS - Frequently Asked Questions (FAQ)

What is the current Regulus Therapeutics share price?
The current share price of Regulus Therapeutics is US$ 1,05
How many Regulus Therapeutics shares are in issue?
Regulus Therapeutics has 65 500 134 shares in issue
What is the market cap of Regulus Therapeutics?
The market capitalisation of Regulus Therapeutics is USD 65,5M
What is the 1 year trading range for Regulus Therapeutics share price?
Regulus Therapeutics has traded in the range of US$ 0,8301 to US$ 3,78 during the past year
What is the PE ratio of Regulus Therapeutics?
The price to earnings ratio of Regulus Therapeutics is -2,18
What is the reporting currency for Regulus Therapeutics?
Regulus Therapeutics reports financial results in USD
What is the latest annual profit for Regulus Therapeutics?
The latest annual profit of Regulus Therapeutics is USD -30,04M
What is the registered address of Regulus Therapeutics?
The registered address for Regulus Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Regulus Therapeutics website address?
The website address for Regulus Therapeutics is www.regulusrx.com
Which industry sector does Regulus Therapeutics operate in?
Regulus Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
REBNReborn Coffee Inc
US$ 3,31
(63,05%)
55,54M
FCUVFocus Universal Inc
US$ 5,87
(56,62%)
1,73M
SOPASociety Pass Inc
US$ 1,54
(56,50%)
13,82M
CYCNCyclerion Therapeutics Inc
US$ 3,92
(54,33%)
82,39M
ENVBEnveric Biosciences Inc
US$ 2,0899
(-46,41%)
1,57M
NIVFNewGenIvf Group Ltd
US$ 0,1489
(-42,51%)
14,8M
GLSTGlobal Star Acquisition Inc
US$ 8,83
(-39,10%)
23,89k
PRPHProPhase Labs Inc
US$ 0,2633
(-38,02%)
872,46k
SPGCSacks Parente Golf Inc
US$ 0,5601
(-37,86%)
7,27M
TCTMTCTM Kids IT Education Inc
US$ 0,764
(321,87%)
729,72M
NVDANVIDIA Corporation
US$ 120,07
(-3,67%)
388,54M
RIMEAlgorhythm Holdings Inc
US$ 0,02565
(5,12%)
338,75M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0355
(-11,25%)
236,29M
CLEUChina Liberal Education Holdings Ltd
US$ 0,1938
(30,77%)
234,8M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
RGLS
Regulus Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces